SCHEMBL2364282

SCHEMBL2364282

Cc1ccc(-c2ccc(Cl)cc2)cc1O

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.65
ESR2 Q92731 2/20 0.48
TSHR P16473 1/20 0.45
CASP1 P29466 1/20 0.45
APP P05067 1/20 0.42
PTGS1 P23219 2/20 0.42
ACHE P22303 1/20 0.42
TRPA1 O75762 1/20 0.42
CACNA1C Q13936 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
AHR P35869 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
PTGS2 P35354 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47861 0.86 TSHR (0.56) ALOX5ESR2TSHRCASP1APP
SCHEMBL1007614 0.82 MCL1 (0.52) ALOX5TSHRCASP1APPPTGS1
SCHEMBL172727 0.81
SCHEMBL30573008 0.81
SCHEMBL1005170 0.80 ALOX5 (0.64) ALOX5ESR2TSHRCASP1APP
SCHEMBL29563142 0.79 ALOX5 (1.00) ALOX5ESR2TSHRAPPAHR
SCHEMBL5047034 0.79 ALOX5 (0.48) ALOX5ESR2TSHRAHRCYP1A2
SCHEMBL14295102 0.79 MCL1 (0.57) ALOX5ESR2TSHRCASP1APP
SCHEMBL12387990 0.79 APP (0.70) ALOX5TSHRCASP1APPPTGS1
SCHEMBL1629674 0.79 NPC1 (0.56) TSHRACHENPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289823-A1 SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES Medshine Discovery Inc. (CN) 2023-12-13 EP disclosed
EP-2536686-A1 CYCLIC KETO-ENOLS FOR THERAPY Bayer Intellectual Property GmbH (DE) 2012-12-26 EP disclosed
WO-2011098433-A1 CYCLIC KETO-ENOLS FOR THERAPY BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-08-18 WO disclosed